Literature DB >> 9164372

Hemodynamic changes after cardioversion of chronic atrial fibrillation.

C B Upshaw1.   

Abstract

After cardioversion of chronic atrial fibrillation to sinus rhythm, there is a gradual increase of 56% in cardiac output over 4 weeks. The increase is caused by the gradual return and increasing strength of left atrial mechanical activity as the atrial myopathy of chronic atrial fibrillation subsides. Cardiac output decreases after cardioversion of atrial fibrillation in more than a third of patients, and the decrease may last a week. Acute pulmonary edema is uncommon; 50% of cases occur within 3 hours of cardioversion, with a mortality of 18%. The reduced cardiac performance after cardioversion most likely results from the combination of heart disease and cardiac depressant effects of anesthetic drugs used. Pulmonary and/or coronary artery emboli and the resumption of right atrial mechanical activity before left atrial mechanical activity may be additional factors in the pathogenesis of pulmonary edema after cardioversion. Anticoagulant therapy should be continued for a month or longer after cardioversion in those patients who maintain sinus rhythm to prevent thromboembolism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9164372

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  10 in total

Review 1.  Physiology and pathophysiology of the atria: its role in atrial fibrillation.

Authors:  J Godtfredsen
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

2.  Cardioversion and the use of sedation.

Authors:  S J Harrison; J Mayet
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

3.  Reduced prevalence of atrial fibrillation in black patients compared with white patients attending an urban hospital: an electrocardiographic study.

Authors:  Charles B Upshaw
Journal:  J Natl Med Assoc       Date:  2002-04       Impact factor: 1.798

4.  Restoring normal sinus rhythm in atrial fibrillation : evidence from pharmacologic therapy and catheter ablation trials.

Authors:  Peter Zimetbaum
Journal:  Curr Cardiol Rep       Date:  2006-09       Impact factor: 2.931

Review 5.  Atrial fibrillation, cognition and dementia: A review.

Authors:  Summer Aldrugh; Mayank Sardana; Nils Henninger; Jane S Saczynski; David D McManus
Journal:  J Cardiovasc Electrophysiol       Date:  2017-06-21

Review 6.  Cost effectiveness of therapies for atrial fibrillation. A review.

Authors:  M P Teng; L E Catherwood; D P Melby
Journal:  Pharmacoeconomics       Date:  2000-10       Impact factor: 4.981

7.  Pulmonary edema post-cardioversion: a potential calcium signalling problem.

Authors:  Ahmad Hersi; Paul W Armstrong; Jonathan B Choy; Sajad Gulamhusein; Katherine M Kavanagh
Journal:  Can J Cardiol       Date:  2006-03-01       Impact factor: 5.223

Review 8.  Anti-thrombotic strategies for patients with atrial fibrillation and heart failure.

Authors:  Mary Norine Walsh; Eric N Prystowsky
Journal:  Heart Fail Rev       Date:  2002-07       Impact factor: 4.214

9.  External Cardioversion of Atrial Fibrillation Causes an Early Improvement of Cardiac Performance: A Longitudinal Strain Analysis Study.

Authors:  Stefano Fumagalli; Debbie Gabbai; Sara Francini; Marta Casalone Rinaldi; Stefano Pedri; Samuele Baldasseroni; Francesca Tarantini; Claudia Di Serio; Giuseppe Lonetto; Mauro Di Bari; Luigi Padeletti; Harry J Crijns; Niccolò Marchionni
Journal:  J Cardiovasc Echogr       Date:  2014 Jan-Mar

10.  Atrial Fibrillation and Dementia: Epidemiological Insights on an Undervalued Association.

Authors:  Andrea Saglietto; Andrea Ballatore; Henri Xhakupi; Gaetano Maria De Ferrari; Matteo Anselmino
Journal:  Medicina (Kaunas)       Date:  2022-03-01       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.